A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALS-008176; Drug: Placebo
Sponsor: Alios Biopharma Inc.
Completed - verified January 2017
Interventions: Drug: ALS-008176; Drug: Placebo
Sponsor: Alios Biopharma Inc.
Completed - verified January 2017